Skip to main content
Glioblastoma Navigator
en
English
Italian
Centers
Clinical Trials
User Menu
Log in
Clinical Trials
Required Karnofsky score
Please select a Karnofsky value
100 - Normal; no complaints; no evidence of disease.
90 - Able to carry on normal activity; minor signs or symptoms of disease.
80 - Normal activity with effort; some signs or symptoms of disease.
70 - Cares for self; unable to carry on normal activity or to do active work.
60 - Requires occasional assistance, but is able to care for most of their personal needs.
50 - Requires considerable assistance and frequent medical care.
40 - Disabled; requires special care and assistance.
30 - Severely disabled; hospital admission is indicated although death not imminent.
20 - Very sick; hospital admission necessary; active supportive treatment necessary.
10 - Moribund; fatal processes progressing rapidly.
Mutations
- Any -
MGMT
MGMT Unmethylated
IDH1
IDH2
IDH wild-type
EGFR
FGFR
VEGFR
G-CIMP
TP53
ATRX
TERT
Chromosome 10
Chromosome 1p/19q
RB
XPO1
Vaccinazione con cellule dendritiche autologhe caricate con omogenato di tumore autologo nel glioblastoma (Combi G-Vax)
Required Karnofsky
70
Phase
Phase II
Tumor Type
Glioblastoma
Type of Diagnosis
New Diagnosis
Center
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)
Read more
Pagination
First page
« First
Previous page
‹‹
Page
1
Current page
2